Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521

Watchlist Manager
Zhejiang Huahai Pharmaceutical Co Ltd Logo
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Watchlist
Price: 18.7 CNY -0.58% Market Closed
Market Cap: 27.4B CNY
Have any thoughts about
Zhejiang Huahai Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhejiang Huahai Pharmaceutical Co Ltd stock under the Base Case scenario is 29.69 CNY. Compared to the current market price of 18.7 CNY, Zhejiang Huahai Pharmaceutical Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
29.69 CNY
Undervaluation 37%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
87
vs Industry
39
Median 3Y
3.1
Median 5Y
4
Industry
2.5
Forward
2.8
vs History
88
vs Industry
17
Median 3Y
25.6
Median 5Y
37.7
Industry
21.8
Forward
22.6
vs History
84
vs Industry
36
Median 3Y
17.7
Median 5Y
21
Industry
16.1
vs History
53
vs Industry
26
Median 3Y
24.4
Median 5Y
21.4
Industry
23.8
vs History
84
vs Industry
25
Median 3Y
3.3
Median 5Y
4.2
Industry
2.1
vs History
85
vs Industry
33
Median 3Y
3.7
Median 5Y
4.4
Industry
2.7
Forward
3.2
vs History
93
vs Industry
37
Median 3Y
6.2
Median 5Y
7.5
Industry
5.2
vs History
92
vs Industry
19
Median 3Y
19.4
Median 5Y
26.6
Industry
13.5
Forward
11.5
vs History
92
vs Industry
22
Median 3Y
19.4
Median 5Y
26.6
Industry
16.8
Forward
17.9
vs History
87
vs Industry
35
Median 3Y
21.1
Median 5Y
22.7
Industry
15.2
vs History
38
vs Industry
17
Median 3Y
-20.6
Median 5Y
24.6
Industry
19.3
vs History
79
vs Industry
37
Median 3Y
2
Median 5Y
2.4
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Zhejiang Huahai Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
27.4B CNY 2.9 24.1 17.8 17.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
CN
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Average P/E: 31.4
24.1
83%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CN
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Average EV/EBITDA: 415.3
17.8
111%
0.2
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CN
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Average EV/EBIT: 1 811.9
17.8
51%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top